These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11365973)
1. New study of Fortovase (Saquinavir) in women. WORLD; 1998 Nov; (No 91):4. PubMed ID: 11365973 [TBL] [Abstract][Full Text] [Related]
2. Do women respond differently to HIV therapy than men? Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087 [TBL] [Abstract][Full Text] [Related]
3. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
4. Are men and women really different? Res Initiat Treat Action; 1998 Dec; 4(7):13. PubMed ID: 11366080 [TBL] [Abstract][Full Text] [Related]
8. Saquinavir, the pioneer antiretroviral protease inhibitor. la Porte CJ Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048 [TBL] [Abstract][Full Text] [Related]
9. Saquinavir (Fortovase or Invirase). Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182 [No Abstract] [Full Text] [Related]
10. Study to address effects of antiretroviral therapy on women. Hanna L BETA; 1999 Apr; 12(2):16. PubMed ID: 11366677 [TBL] [Abstract][Full Text] [Related]
11. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047 [No Abstract] [Full Text] [Related]
12. Fortovase approved: new saquinavir formulation. James JS AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907 [TBL] [Abstract][Full Text] [Related]
13. Saquinavir/low-dose ritonavir: its use in HIV infection. Johnson M; Peters B AIDS Rev; 2003; 5(1):44-51. PubMed ID: 12875107 [TBL] [Abstract][Full Text] [Related]
14. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers. James JS AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073 [TBL] [Abstract][Full Text] [Related]
15. Saquinavir as Fortovase: why does it matter? Trapnell CB AIDS Clin Care; 1998 May; 10(5):37, 40. PubMed ID: 11365428 [TBL] [Abstract][Full Text] [Related]
16. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir. TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837 [No Abstract] [Full Text] [Related]
17. Saquinavir (Roche protease inhibitor) at higher doses. AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870 [TBL] [Abstract][Full Text] [Related]
18. What they say about protease inhibitors. Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection. Wheat LJ; Farthing C; Cohen C; Pierone G; Lalezari J; Pilson RS; Siemon-Hryczyk P; Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388 [TBL] [Abstract][Full Text] [Related]
20. Saquinavir/Ritonavir: its evolution and current treatment role. O'Brien WA AIDS Read; 2006 Jan; 16(1):38-44; discussion 43. PubMed ID: 16433471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]